ACD-A (Fenwal Inc.)
Welcome to the PulseAid listing for the ACD-A drug offered from Fenwal Inc.. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fenwal Inc. |
NON-PROPRIETARY NAME: | Antiocoagulant Citrate Dextrose Solution, Formula A |
SUBSTANCE NAME: | DEXTROSE MONOHYDRATE; SODIUM CITRATE; ANHYDROUS CITRIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-10-24 |
END MARKETING DATE: | 0000-00-00 |
ACD-A HUMAN PRESCRIPTION DRUG Details:
Item Description | ACD-A from Fenwal Inc. |
LABELER NAME: | Fenwal Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.45; 2.2; 730(g/100mL; g/100mL; mg/100mL) |
START MARKETING DATE: | 2012-10-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0942-9005_bf4444ef-bff1-46c8-b11d-99091f14262d |
PRODUCT NDC: | 0942-9005 |
APPLICATION NUMBER: | BN160918 |
Other DEXTROSE MONOHYDRATE; SODIUM CITRATE; ANHYDROUS CITRIC ACID Pharmaceutical Manufacturers / Labelers: